L-Histidine: failure to affect the sleep-waking cycle in man

Area of Science:

• Neuroscience
• Sleep Medicine
• Pharmacology

Background:

• Narcolepsy is a chronic neurological disorder affecting sleep-wake cycles.
• The role of histamine as a potential neurotransmitter in wakefulness is under investigation.
• Previous hypotheses suggested histamine might be a key factor in maintaining wakefulness.

Purpose of the Study:

• To investigate the effects of L-Histidine supplementation on sleep patterns and narcolepsy symptoms.
• To evaluate the hypothesis that histamine acts as a waking factor.

Main Methods:

• L-Histidine was administered to patients with narcolepsy and healthy volunteers.
• Dosages varied: 20 g/day for 2 weeks (narcolepsy patients), 32.4 g/day for 5 days (volunteers), and 48.6 g/day for 16 days (scleroderma patient).
• Nocturnal electroencephalogram (EEG) sleep patterns were monitored.

Main Results:

• No significant changes were observed in nocturnal EEG sleep patterns across all participants.
• L-Histidine administration did not alleviate symptoms in patients with narcolepsy.
• No beneficial effects were noted in the patient with progressive systemic sclerosis.

Conclusions:

• The study failed to provide evidence supporting the hypothesis that histamine is a waking factor.
• L-Histidine supplementation is not an effective treatment for narcolepsy symptoms or sleep disturbances.
• Further research is needed to fully elucidate the role of histamine in sleep-wake regulation.